A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Nektar Therapeutics (NASDAQ:NKTR) is one of the best hot stocks to buy according to Wall Street analysts. On June 24, Nektar ...

Despite Nektar’s share price shooting up as much as 175% on Tuesday, William Blair maintained that “there is an absence of ...

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.

Figure skater Michelle Hong used to hide her skin as much as possible due to her condition—but with effective treatment and ...

Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a midstage study of its eczema treatment.

A team of researchers led by the University of Exeter have been awarded a £3.3 million grant by the Medical Research Council ...

A team led by the University of Exeter, and including researchers from King's College London, has been awarded a £3.3 million ...